| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Amneal Pharmaceuticals, Inc. | Co-CEO, Director | Class A Common Stock | 24.8M | $219M | $8.84 | 03 Mar 2025 | By Family Trusts |
| Amneal Pharmaceuticals, Inc. | Co-CEO, Director | Performance-Based Restricted Stock Units | 890K | $7.87M | $8.84 | 03 Mar 2025 | Direct |
| Amneal Pharmaceuticals, Inc. | Co-CEO, Director | Class A Common Stock | 864K | $7.64M | $8.84 | 04 Mar 2025 | Direct |
| Amneal Pharmaceuticals, Inc. | Co-CEO, Director | Restricted Stock Units | 278K | $2.46M | $8.84 | 04 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AMRX | Amneal Pharmaceuticals, Inc. | 03 Mar 2025 | 8 | -$2.81M | 4 | Co-CEO, Director | 05 Mar 2025, 19:31 |
| AMRX | Amneal Pharmaceuticals, Inc. | 04 Mar 2024 | 2 | $0 | 4 | Co-CEO, Director | 06 Mar 2024, 17:40 |
| AMRX | Amneal Pharmaceuticals, Inc. | 07 Nov 2023 | 2 | $0 | 4 | Co-CEO, Director | 08 Nov 2023, 18:20 |
| AMRX | Amneal Pharmaceuticals, Inc. | 03 Mar 2023 | 1 | $0 | 4 | Co-CEO, Director | 07 Mar 2023, 17:00 |
| AMRX | Amneal Pharmaceuticals, Inc. | 03 Mar 2022 | 1 | $0 | 4 | Co-CEO, Director | 03 Mar 2022, 20:19 |
| AMRX | Amneal Pharmaceuticals, Inc. | 15 Dec 2021 | 2 | $626K | 4 | Co-CEO, Director | 17 Dec 2021, 15:15 |